ShareHope Medicine Co Ltd
ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. It is involved in the health management and operation activities; human resource dispatch of professional medical staff; provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in … Read more
ShareHope Medicine Co Ltd (8403) - Net Assets
Latest net assets as of September 2025: NT$4.02 Billion TWD
Based on the latest financial reports, ShareHope Medicine Co Ltd (8403) has net assets worth NT$4.02 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$6.76 Billion) and total liabilities (NT$2.75 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$4.02 Billion |
| % of Total Assets | 59.4% |
| Annual Growth Rate | 9.97% |
| 5-Year Change | 11.23% |
| 10-Year Change | N/A |
| Growth Volatility | 12.23 |
ShareHope Medicine Co Ltd - Net Assets Trend (2017–2024)
This chart illustrates how ShareHope Medicine Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ShareHope Medicine Co Ltd (2017–2024)
The table below shows the annual net assets of ShareHope Medicine Co Ltd from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$3.98 Billion | +0.65% |
| 2023-12-31 | NT$3.96 Billion | -3.50% |
| 2022-12-31 | NT$4.10 Billion | +5.55% |
| 2021-12-31 | NT$3.88 Billion | +8.50% |
| 2020-12-31 | NT$3.58 Billion | +32.53% |
| 2019-12-31 | NT$2.70 Billion | +5.42% |
| 2018-12-31 | NT$2.56 Billion | +25.15% |
| 2017-12-31 | NT$2.05 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to ShareHope Medicine Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 127.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$819.98 Million | 23.05% |
| Other Components | NT$2.74 Billion | 76.95% |
| Total Equity | NT$3.56 Billion | 100.00% |
ShareHope Medicine Co Ltd Competitors by Market Cap
The table below lists competitors of ShareHope Medicine Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Imagicaaworld Entertainment Limited
NSE:IMAGICAA
|
$63.70 Million |
|
Gas Plus S.p.A.
LSE:0EMK
|
$63.72 Million |
|
Windlas Biotech Limited
NSE:WINDLAS
|
$63.73 Million |
|
Micro Systemation AB Series B
LSE:0FBM
|
$63.78 Million |
|
Waratah Minerals Limited
F:0FS0
|
$63.70 Million |
|
Talbros Automotive Components Limited
NSE:TALBROAUTO
|
$63.70 Million |
|
Kumpulan Perangsang Selangor
KLSE:5843
|
$63.68 Million |
|
SESHAASAI TECHNOLOGIES L
NSE:STYL
|
$63.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ShareHope Medicine Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,487,936,000 to 3,556,895,000, a change of 68,959,000 (2.0%).
- Net income of 200,097,000 contributed positively to equity growth.
- Share repurchases of 9,000,000 reduced equity.
- Other factors decreased equity by 68,274,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$200.10 Million | +5.63% |
| Share Repurchases | NT$9.00 Million | -0.25% |
| Other Changes | NT$-68.27 Million | -1.92% |
| Total Change | NT$- | 1.98% |
Book Value vs Market Value Analysis
This analysis compares ShareHope Medicine Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.87x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.16x to 0.87x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$19.36 | NT$22.55 | x |
| 2018-12-31 | NT$20.93 | NT$22.55 | x |
| 2019-12-31 | NT$22.26 | NT$22.55 | x |
| 2020-12-31 | NT$22.51 | NT$22.55 | x |
| 2021-12-31 | NT$24.74 | NT$22.55 | x |
| 2022-12-31 | NT$26.94 | NT$22.55 | x |
| 2023-12-31 | NT$27.55 | NT$22.55 | x |
| 2024-12-31 | NT$25.84 | NT$22.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ShareHope Medicine Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.63%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.63%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 2.00x
- Recent ROE (5.63%) is below the historical average (6.79%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 6.67% | 4.75% | 0.78x | 1.80x | NT$-61.97 Million |
| 2018 | 6.18% | 4.77% | 0.79x | 1.63x | NT$-90.10 Million |
| 2019 | 7.77% | 6.24% | 0.74x | 1.68x | NT$-55.92 Million |
| 2020 | 8.49% | 6.04% | 0.72x | 1.95x | NT$-44.11 Million |
| 2021 | 7.39% | 6.04% | 0.63x | 1.94x | NT$-82.22 Million |
| 2022 | 8.60% | 7.11% | 0.56x | 2.16x | NT$-47.98 Million |
| 2023 | 3.57% | 3.22% | 0.52x | 2.13x | NT$-224.24 Million |
| 2024 | 5.63% | 4.63% | 0.61x | 2.00x | NT$-155.59 Million |
Industry Comparison
This section compares ShareHope Medicine Co Ltd's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $7,715,414,000
- Average return on equity (ROE) among peers: 6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ShareHope Medicine Co Ltd (8403) | NT$4.02 Billion | 6.67% | 0.68x | $63.70 Million |
| Excelsior Medical Co Ltd (4104) | $10.30 Billion | 6.48% | 0.60x | $236.51 Million |
| CHC Healthcare Group (4164) | $5.13 Billion | 6.30% | 1.11x | $134.14 Million |